A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast cancer reveals novel mechanisms of the metabolic-immune interaction that ...
BBO-11818 showed significant tumor growth inhibition across multiple tumor types in preclinical models and demonstrated ...
Houston Methodist scientists have uncovered an unexpected side of a protein best known for its link to brain diseases. The ...
More than 200 metabolic enzymes, many of which are normally tasked with producing energy in the mitochondria, are also found ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...
Can the bend of a banana give us insight into cancer? What does the shape of a rice grain have to do with infertility? The ...
Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR exon 20 insertion mutant NSCLC expected mid-2026Global pivotal Phase 3 ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients ...
New findings show how inherited and acquired genetic mutations cause breast cancer resistance to CDK4/6 inhibitors.
The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...
This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...
The FDA has granted accelerated approval to zongertinib (Hernexeos) for the treatment of adults with unresectable or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results